ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Breast Cancer
Ovarian Cancer
Endometrial Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma

Prostate Cancer trials near Berlin, BE, DEU:

Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.

This is a phase III, randomized, open-label, multi-center study to assess the efficacy of treatment intensification with docetaxel plus apalutamide a...

Begins enrollment in 2 months
Metastatic Hormone-sensitive Prostate Cancer
Drug: Apalutamide (Erleada™) 60 mg or 240 mg tablets
Drug: Docetaxel

Phase 3

Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD

Berlin, Germany and 55 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Berlin, Germany and 378 other locations

survival (rPFS) per 1) Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 for soft tissue and/or Prostate Cancer Wo...

Active, not recruiting
Hormone-Sensitive Prostate Cancer
Drug: Capivasertib
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 322 other locations

Locations recently updated

The main objective of the study is to compare overall survival in participants receiving xaluritamig versus investigator's choice (cabazitaxel or sec...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: Cabazitaxel
Drug: Enzalutamide

Phase 3

Amgen
Amgen

Berlin, Germany and 160 other locations

The purpose of the study is to assess and evaluate dosimetry, safety, and tolerability following administration of up to 12 cycles of (177Lu) vipivot...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: Gonadotropin-releasing hormone (GnRH) analogues
Drug: AAA617

Phase 1

Novartis
Novartis

Berlin, Germany and 20 other locations

Researchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.BCR means tha ...

Active, not recruiting
Biochemically Recurrent Prostate Cancer
Other: Placebo matching darolutamide
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 3

Bayer
Bayer

Berlin, Berlin, Germany and 237 other locations

hormonal therapy (NHT) in men with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with on ...

Active, not recruiting
Metastatic Prostate Cancer
Prostate Adenocarcinoma
Drug: Cabozantinib
Drug: Abiraterone Acetate

Phase 3

Exelixis
Exelixis

Berlin, Germany and 279 other locations

Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a ...

Enrolling
Prostatic Neoplasms
Prostate Cancer
Drug: Ifinatamab deruxtecan
Drug: Prednisone

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Berlin, Germany and 249 other locations

vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC) progressing after definitive therapy to ...

Enrolling
Oligometastatic Prostate Cancer (OMPC)
Drug: AAA617

Phase 3

Novartis
Novartis

Berlin, Germany and 135 other locations

The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA...

Enrolling
Metastatic Castration-Sensitive Prostate Cancer
Drug: Abiraterone Acetate
Drug: Darolutamide

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 407 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems